Crohn Disease
📧 Sign up to get email alerts when something new happens for Crohn Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-08-13Clinical Trial Update: Mesentery Guide Identify Microscopic Clean Resection and Reduces Crohn's Endoscopic Recurrence
A completed clinical trial evaluating a mesentery-guided surgical approach for Crohn's disease reported achieving microscopic clean resectio…
-
CLINICAL_TRIALS research · 2024-08-12Clinical Trial Update: Longitudinal Study on Bacterial Production of LPC and LPA in Patients With Inflammatory Bowel Disease
A longitudinal clinical trial studying bacterial production of lysophosphatidylcholine (LPC) and lysophosphatidic acid (LPA) in patients wit…
-
CLINICAL_TRIALS trial_result · 2024-08-06Clinical Trial Update: A Study on How Vedolizumab is Given and the Outcomes for Adults With Inflammatory Bowel Disease (VARIETY-Belgium)
A completed study assessing how vedolizumab is administered and the outcomes in adults with inflammatory bowel disease (VARIETY-Belgium).
-
CLINICAL_TRIALS trial_result · 2024-08-05Clinical Trial Update: A Study of the Quality of Life in Adults With Crohn's Disease With Complex Perianal Fistulas
The study on quality of life in adults with Crohn disease and complex rectal fistulas has completed and posted its results.
-
CLINICAL_TRIALS research · 2024-08-01Clinical Trial Update: Seeded Cells on Matrix Plug Treating Crohn's Perianal Fistulas (STOMP-II) [Phase 2]
Phase 2 clinical trial STOMP-II using seeded cells on a matrix plug to treat Crohn's disease-associated perianal fistulas; status is active …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-07-31Clinical Trial Update: Pharmacokinetics, Efficacy and Safety of CT-P13 Subcutaneous as Induction Therapy in Patients With Active CD or UC [Phase 3]
Phase 3 clinical trial evaluating pharmacokinetics, efficacy and safety of subcutaneous CT-P13 as induction therapy in adults with active Cr…
-
CLINICAL_TRIALS withdrawal · 2024-07-31Clinical Trial Update: Phase 2b/3 Study of ABX464 in Moderate to Severe Active Crohn's Disease Patients [Phase 2, Phase 3]
The Phase 2b/3 study of ABX464 in moderate to severe active Crohn's disease has been withdrawn.
-
FDA approval · 2024-07-30FDA Approved: MESALAMINE — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved a supplemental application for MESALAMINE from ANI Pharmaceuticals, Inc.
-
CLINICAL_TRIALS research · 2024-07-26Clinical Trial Update: Clinical Efficacy of Ustekinumab in Crohn's Disease
This document provides an update on a clinical trial evaluating the efficacy of ustekinumab in Crohn's disease, which is currently in recrui…
-
CLINICAL_TRIALS research · 2024-07-26Clinical Trial Update: Subcutaneous Infliximab After A Previous Intravenous Dose Optimization [Phase 4]
Phase 4 trial update evaluating subcutaneous infliximab after previous intravenous dose optimization for inflammatory bowel diseases, includ…
-
CLINICAL_TRIALS research · 2024-07-25Clinical Trial Update: Efficacy and Safety of Bowel Preparation for Patency Capsule in CD Patients Who Previously Failed Patency Capsule
A clinical trial assesses bowel preparation for a patency capsule in Crohn's disease patients who previously failed a patency capsule; the s…
-
CLINICAL_TRIALS trial_result · 2024-07-22Clinical Trial Update: A Study of Vedolizumab in Adults in Real-World Practice
This real-world study of Vedolizumab in adults with ulcerative colitis or Crohn's disease has completed. It evaluated treatment outcomes in …
-
CLINICAL_TRIALS research · 2024-07-22Clinical Trial Update: USTekinumab in Fistulising Perianal Crohn's Disease (USTAP) [Phase 4]
Phase 4 clinical trial update for ustekinumab in fistulising perianal Crohn's disease; the study is currently active but not recruiting.
-
CLINICAL_TRIALS other · 2024-07-19Clinical Trial Update: Expanded Access Protocol for STOMP-II Patients Who Were Unable to Receive Treatment Subsequent to Adipose Tissue Collection
This update describes an expanded access protocol for STOMP-II patients who were unable to receive treatment after adipose tissue collection…
-
CLINICAL_TRIALS research · 2024-07-18Clinical Trial Update: AI-enabled Endoscopic Prediction of Post-operative Recurrence in Crohn's Disease
A University College Cork trial uses AI-enabled endoscopy to predict post-operative recurrence in Crohn's disease and is currently recruitin…
-
CLINICAL_TRIALS research · 2024-07-11Clinical Trial Update: IBD Registry in a Sub-Saharan African Population
A Sub-Saharan Africa inflammatory bowel disease registry is recruiting participants at the University of Zimbabwe, focusing on ulcerative co…
-
CLINICAL_TRIALS trial_result · 2024-07-10Clinical Trial Update: Adalimumab Trough Concentrations in Crohn's Disease: A Pilot Pharmacokinetic Study
A completed pilot pharmacokinetic study evaluated adalimumab trough concentrations in Crohn's disease to characterize drug exposure.
-
CLINICAL_TRIALS trial_result · 2024-07-10Clinical Trial Update: Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease [Phase 3]
A Phase 3 long-term extension study of filgotinib in adults with Crohn's disease has been terminated, and the results have been posted.
-
FDA approval · 2024-07-09FDA Approved: MERCAPTOPURINE — Supplemental Application (Nova Laboratories, Ltd)
The FDA approved a supplemental application for mercaptopurine (Purixan) by Nova Laboratories, Ltd., updating the product labeling and/or in…
-
FDA approval · 2024-07-09FDA Approved: MERCAPTOPURINE — Supplemental Application (Florida Pharmaceutical Products, LLC)
FDA approved a supplemental application for Mercaptopurine submitted by Florida Pharmaceutical Products, LLC.
-
CLINICAL_TRIALS trial_result · 2024-07-03Clinical Trial Update: An Investigational Study of Experimental Medication BMS-986165 in Participants With Moderate to Severe Crohn's Disease [Phase 2]
A Phase 2 trial of BMS-986165 in moderate-to-severe Crohn's disease was terminated, and results have been posted. The update provides the as…
-
CLINICAL_TRIALS trial_result · 2024-07-03Clinical Trial Update: The Innate Immune Response and Enteric Nervous System in Crohn's Disease.
A Crohn's disease clinical trial studying the innate immune response and enteric nervous system was terminated.
-
CLINICAL_TRIALS research · 2024-07-03Clinical Trial Update: Spatially Resolved IBD: Spatial Transcriptomics of Inflammatory Bowel Disease (IBD)
This clinical trial registered by IRCCS San Raffaele investigates spatial transcriptomics in inflammatory bowel disease and is set to enroll…
-
CLINICAL_TRIALS research · 2024-07-03Clinical Trial Update: COmbinAtion Therapy of dieT With biologicalS for Crohn's Disease: the OATS Study [NA]
The OATS study is recruiting to evaluate the combination of dietary therapy with biological treatments for Crohn's disease at KU Leuven.
-
CLINICAL_TRIALS trial_result · 2024-07-01Clinical Trial Update: A Study to Evaluate the Effect of Intravenous (IV) Infusions of Risankizumab on Pharmacokinetics of Cytochome P450 Substrates in Adult Participants With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease [Phase 1]
A Phase 1 study assessing whether intravenous risankizumab alters the pharmacokinetics of cytochrome P450 substrates in adults with moderate…